おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
KelSie Biotech
company
About
KelSie Biotech develops high bioavailability delivery methods to formulate and deliver sensitive active pharmaceutical ingredients.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
KelSie Biotech is a biotech company that develops high bioavailability delivery methods to formulate and deliver sensitive Active Pharmaceutical Ingredients (APIs). It develops dry powder inhalable products with patented technology of bubble drying process and sublingual wafer, patients to take their everyday dosages without any difficulty.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
KelSie Biotech has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
May 31, 2019 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 31, 2019 | Series A | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
KelSie Biotech is funded by 1 investors.
Arcadian Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
